Andrea Rabung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrea Rabung has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Carola Meier
Department of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany
2 shared publications - Thomas Tschernig
Institute of Anatomy and Cell Biology, Saarland University, Homburg/Saar, Germany
2 shared publications - Christoph Beisswenger
Department of Internal Medicine V—Pulmonology, Allergology and Respiratory Critical Care Medicine, Saarland University, 66421 Homburg, Germany
1 shared publication - Ebru Diler
Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg/Saar, Germany
1 shared publication - Fabian Garreis
Department of Anatomy II, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany
1 shared publication - Felix Rausch
Department of Anatomy II, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany
1 shared publication
Latest Publications
- Open Access
- 23 November 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 705
Chronic inhalation of cigarette smoke reduces phagocytosis in peripheral blood leukocytes
Phagocytosis activity of peripheral blood leukocytes in smokers or chronic obstructive pulmonary disease patients was found to be controversial and dependent on the phagocytic stimulus. We demonstrated that long-term exposure to cigarette smoke in mice clearly suppressed the phagocytosis of granulocytes and monocytes from peripheral blood. Impaired phagocytosis activity of peripheral blood leukocytes may have a systemic effect and potentially contribute to smoking-associated diseases such as pneumonia and lung cancer.
- 23 November 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 705
Open AccessChronic inhalation of cigarette smoke reduces phagocytosis in peripheral blood leukocytes
Phagocytosis activity of peripheral blood leukocytes in smokers or chronic obstructive pulmonary disease patients was found to be controversial and dependent on the phagocytic stimulus. We demonstrated that long-term exposure to cigarette smoke in mice clearly suppressed the phagocytosis of granulocytes and monocytes from peripheral blood. Impaired phagocytosis activity of peripheral blood leukocytes may have a systemic effect and potentially contribute to smoking-associated diseases such as pneumonia and lung cancer.
- Open Access
- 26 November 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 1-4
The novel surfactant protein SP-H enhances the phagocytosis efficiency of macrophage-like cell lines U937 and MH-S
Surfactant proteins (SP) secreted by alveolar type 2 cells, play an essential role in maintaining the air-liquid barrier of the lung and are also involved in the opsonisation and clearance of bacteria by phagocytes. We have recently described a novel surfactant protein, SP-H (SFTA3). Expression of SP-H was earlier demonstrated to be upregulated by LPS and negatively regulated by IL-1β and IL-23 in vitro. The influence of SP-H on phagocytosis was measured using a murine and a human phagocytic cell line and fluorescent latex beads. SP-H markedly increases phagocytosis in vitro in the murine-derived alveolar macrophage cell lines MH-S and in human-derived differentiated U937 cells. It can be assumed that SP-H is involved in regulating phagocytic activity of macrophages. SP-H is a new player in pulmonary host defence.
- 26 November 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 1-4
Open AccessThe novel surfactant protein SP-H enhances the phagocytosis efficiency of macrophage-like cell lines U937 and MH-S
Surfactant proteins (SP) secreted by alveolar type 2 cells, play an essential role in maintaining the air-liquid barrier of the lung and are also involved in the opsonisation and clearance of bacteria by phagocytes. We have recently described a novel surfactant protein, SP-H (SFTA3). Expression of SP-H was earlier demonstrated to be upregulated by LPS and negatively regulated by IL-1β and IL-23 in vitro. The influence of SP-H on phagocytosis was measured using a murine and a human phagocytic cell line and fluorescent latex beads. SP-H markedly increases phagocytosis in vitro in the murine-derived alveolar macrophage cell lines MH-S and in human-derived differentiated U937 cells. It can be assumed that SP-H is involved in regulating phagocytic activity of macrophages. SP-H is a new player in pulmonary host defence.